Table 3 Univariate analysis between selected parameters and thromboembolism events in patients with anti-PLA2R-positive PMN.
From: Nomogram for thromboembolic events in primary membranous nephropathy associated with PLA2R antibody
Variable | OR(95%CI) | P-valve |
|---|---|---|
Gender (female/ male) | 0.656 (0.430, 1) | 0.05 |
Age (year) | 1.040 (1.023, 1.056) | < 0.001* |
PLA2R-Ab titer > 36.9RU/ml | 3.077 (1.932, 4.899) | < 0.001* |
PLA2R-Ab titer ≤ 36.9RU/ml | 1 | |
Creatinine (µmol/L) | 1.003 (1.001, 1.006) | 0.008* |
24-h proteinuria (g) | 1.081 (1.040, 1.124) | < 0.001* |
Albumin (g/L) | 0.935 (0.904, 0.967) | < 0.001* |
Haemoglobin (g/L) | 0.983 (0.973, 0.992) | < 0.001* |
Platelet (×109/L) | 1.001 (0.998, 1.003) | 0.60 |
Total cholesterol (mmol/l) | 0.982 (0.910, 1.060) | 0.649 |
Low-density lipoprotein (mmol/l) | 0.971 (0.892, 1.056) | 0.489 |
D-Dimer (g/ml) | 1.429 (1.283, 1.593) | < 0.001* |
Fibrinogen (mg/dl) | 1.292 (1.113, 1.499) | 0.001* |
APTT | 1.001 (0.992, 1.020) | 0.443 |
PT | 1.001 (0.970, 1.020) | 0.894 |
